Pyruvate augmentation of contractile function and cytosolic free energy of ATP hydrolysis in myocardium could result from pyruvate 1 catabolism in the mitochondria or from increased ratio of the cytosolic NAD / NADH redox couple via the lactate dehydrogenase equilibrium. Objective: To test the hypothesis that cytosolic oxidation by pyruvate is sufficient to increase cardiac function and energetics. Methods: Isolated working guinea-pig hearts received 0.2 mM octanoate62.5 mM pyruvate as fuels. a-Cyano-3-hydroxycinnamate (COHC, 0.6 mM) was administered to selectively inhibit mitochondrial pyruvate uptake without inhibiting pyruvate's cytosolic 21 redox effects or octanoate oxidation. 
Introduction
K , equilibrium constant of creatine kinase; Mg , cytosolic free mag-CK f nesium; MVO , myocardial oxygen consumption; NMR, nuclear mag- 2 The working myocardium is heavily dependent on netic resonance spectroscopy; PCr, phosphocreatine; P , inorganic phos- in cardiac function and energetics [1] [2] [3] . In this respect, pyruvate has proven particularly effective as a metabolic solic phosphorylation potentials than equimolar concentrations of lactate despite similar mitochondrial [NADH] inotropic agent. Pyruvate augments contractile function in during perfusion with either substrate [12] . isolated [3, 4] and in situ hearts [5] even when other fuels This investigation was undertaken to define the role of are available. Pyruvate-enhanced contractile performance mitochondrial catabolism in mediating pyruvate's inotropic is paralleled by increased thermodynamic state of the and energetic effects in working guinea-pig myocardium. cytosolic free adenylate system, i.e. cytosolic ATP phosMitochondrial pyruvate uptake was blocked with a-cyanophorylation potential [3, 5, 6] ; thus, in pyruvate perfused 3-hydroxycinnamate, a selective inhibitor of the mitomyocardium more free energy is available from ATP chondrial monocarboxylate transporter which does not hydrolysis for energy-consuming processes central to impede sarcolemmal pyruvate uptake nor mitochondrial contractile function. The postulated role of cytosolic oxidation of fatty acids [13] . Inhibition of mitochondrial phosphorylation potential in modulating cardiac function is 21 pyruvate oxidation blunted its favorable effects on cytoexemplified by sarcoplasmic reticular Ca transport, solic phosphorylation potential, sarcoplasmic reticular which is augmented in pyruvate-energized hearts but 21 Ca transport, and contractile function, although transattenuated in hearts depleted of energy reserves by subsarcolemmal entry of exogenous pyruvate into the cytostrate-free perfusion [3] . In isolated rat ventricular carsolic compartment was unimpeded and octanoate oxidation diomyocytes, superfusion with 5 mM pyruvate markedly 21 increased sufficient to maintain the overall rate of oxidaincreased systolic Ca transients and cell shortening tive metabolism. relative to equimolar concentrations of lactate or acetate [7] . Thus, evidence from several different mammalian heart preparations supports the hypothesized mechanistic 2. Methods linkage between pyruvate enhancements of cytosolic ener- 21 getics, sarcoplasmic reticular Ca transport, and ventricu-2. Methodological details of working heart perfusions have and ATP phosphorylation potential effected by the powerbeen described previously [14] [15] [16] . Coronary and aortic ful enzymes lactate dehydrogenase, glyceraldehyde-3-flows were measured by timed collections, and cardiac phosphate dehydrogenase, and phosphoglycerate kinase.
output equalled the sum of coronary and aortic flows. This mechanism could enable pyruvate to directly increase Krebs-Henseleit bicarbonate perfusion media were precytosolic ATP phosphorylation potential by oxidizing the pared as recently described [14] . All media were fortified redox state of the cytosolic pyridine nucleotides; such an with 0.2 mM octanoate as oxidizable energy substrate and effect would be superimposed on the energetic effects of supplemented with 2.5 mM pyruvate and / or 0.6 mM mitochondrial pyruvate oxidation. Indeed, pyruvate has a-cyano-3-hydroxycinnamate (COHC; Sigma, St. Louis, proven more effective than other fuels at increasing the MO, USA) as indicated. Media were not recirculated. cytosolic ATP phosphorylation potential [4, 6, 9] .
The cytosolic redox and adenylate systems were in 2.2. Experimental protocols near-equilibrium in isolated, nonworking guinea-pig hearts metabolizing glucose [10] ; however, these systems could 2.2.1. Protocol I: pyruvate and octanoate oxidation be displaced from near-equilibrium at the higher metabolic
Rates of myocardial pyruvate and octanoate oxidation rates necessary to sustain physiological levels of external 14 14 were assessed from CO formation from C-pyruvate work. Recent reports in isolated working rabbit hearts 2 14 and C-octanoate, respectively. Perfusion media contained [11, 12] have challenged the cytosolic near-equilibrium both 0.2 mM octanoate and 2.5 mM pyruvate; radiohypothesis. These studies demonstrated that cytosolic ATP coronary effluent as dissolved CO or H CO is 6000 heart beats, i.e. 6000 action potential-initiated Ca 2 3 45 trapped by this procedure [15] . Disintegrations per minute pulses. To increase the specific activity of perfusate Ca 14 21 (dpm) of C were computed from counts per minute by and facilitate radiolabeling of intracellular Ca pools, 14 21 correcting for quench. Myocardial CO release from medium Ca concentration was lowered from 1.0 to 0. as previously described [6] . Left ventricular function was to determine the amount of radioactive calcium remaining 21 assessed from stroke work (mJ g ) and power, i.e. stroke in the heart after caffeine infusion. Desiccated left ventri- 21 21 work times heart rate (mJ min g ). Mechanical efcles were pulverized in a porcelain mortar and radioactivificiency was computed as power divided by the energy ty in 50-mg aliquots was determined by scintillation 45 equivalent of consumed O [17, 18] , which was assumed to counting. Counting efficiency of Ca was 99-100% in 2 21 equal 448 J mmol O [19] . Sucrose (300 mM) was venous effluents and 92-94% in powdered ventricle. volume of sucrose distribution as recently described [15] . myocardial C-sucrose content 21 The sucrose distribution space was 0.5660.02 ml g in Additional protocol III experiments (n513) were conthese hearts and was unaltered by pyruvate and / or COHC.
ducted to address the possibility that between-group differAt 50 min, hearts were stop-frozen with Wollenberger 45 ences in caffeine induced Ca release may have arisen clamps precooled to constant temperature in liquid N . 2 45 from Ca trapped in the extracellular space during the Myocardial metabolites were extracted from stop-frozen 45 45 Ca washout period. In these experiments Ca was not hearts as described below.
included in the labeling medium; instead, the cardiac 21 extracellular space was selectively labeled [21, above. C in coronary effluent and powered tissue was Scientific, San Rafael, CA, USA). measured by liquid scintillation counting; counting efficiencies in these fractions were 91 and 43%, respectively. 14 The kinetics of C washout in each heart were de-3. Results termined by ''curve peeling'' analyses of the natural 14 logarithms of coronary venous C release data 3.1. Effects of a-cyano-3-hydroxycinnamate on pyruvate 21 21 (dpm min g dry ) as described by Becker et al. [22] . and octanoate oxidation 14 Three kinetic components could be resolved from the C washout curves. Component III was the only significant The effects of COHC, a selective inhibitor of the 14 source of C release between 5 and 10 min washout; the mitochondrial monocarboxylate transporter, were ex-14 contribution of this component to total C release at amined in hearts metabolizing 0.2 mM octanoate and 2.5 earlier time points was determined by extrapolating its mM pyruvate as fuels. Rates of octanoate and pyruvate 14 14 linear regression at 5-10 min to the beginning of C oxidation were assessed from formation of CO from curve. Half times of elimination (i.e., t ) and apparent 0.04560.008 mmol min g , respectively. Subsequent
distribution volumes (i.e., V ) of each kinetic component infusion of 0.6 mM COHC elicited a rapid decline in sat 14 14 were computed as previously described [22] . CO formation from [1-C]pyruvate to 35% of baseline 2 14 and a reciprocal threefold increase in CO formation 2 
Metabolite extractions
Myocardial metabolites in protocol II hearts were extracted by standard procedures of our laboratory [15, 23] and enzymatically assayed [24] in a Perkin-Elmer Lambda 2 UV-vis spectrophotometer. At the conclusion of each assay known amounts of metabolite standards were added to assure that the expected absorbance changes were obtained. Inorganic phosphate (P ), pyruvate and lactate i were also measured in perfusion media and coronary venous effluent [15] computed from CO formation in these hearts are only simultaneously (Fig. 2C ). Gross mechanical efficiency was 2 estimates. Substantial amounts of citrate were generated in taken as the ratio of power divided by the energy equivapyruvate perfused hearts (see below), indicating significant lent of consumed oxygen (Fig. 2D) . None of these pyruvate carboxylation. Under such anaplerotic conditions, variables differed among the four groups during the 14 14 CO could be generated from [1-C] did not alter contractile function in pyruvate-free hearts, it tracellular lactate and pyruvate concentrations were meaprevented the enhancements of function and mechanical sured to assess the effects of COHC and pyruvate on the efficiency by pyruvate infusion: stroke work, power, and cytosolic redox state (Table 1) . In pyruvate-free hearts, mechanical efficiency of COHC-treated hearts during COHC significantly increased lactate concentration but did pyruvate infusion did not differ from the respective levels not appreciably alter the pyruvate / lactate ratio. Exogenous in untreated and COHC-treated hearts receiving NaCl 2.5 mM pyruvate increased intracellular pyruvate coninfusions (Fig. 2) 44%, relative to control hearts infused with NaCl. These If COHC selectively inhibited mitochondrial but not pyruvate-induced changes in energy metabolites were sarcolemmal pyruvate uptake, then myocardial contents of lessened or prevented by COHC. Thermodynamic meacytosolic pyruvate metabolites should have been unsures of cytosolic energetics were enhanced by pyruvate, changed or even increased by COHC, while products of and COHC blunted these enhancements as well. Thus, mitochondrial pyruvate metabolism should have been pyruvate increased phosphocreatine potential 241%, and lowered. Alanine, a product of cytosolic pyruvate transcytosolic ATP phosphorylation potential, assessed from the amination, and citrate, generated by anaplerotic flux of creatine kinase equilibrium, 3.5-fold. COHC did not alter mitochondrial pyruvate into the TCA cycle intermediate energy metabolites or phosphorylation potential in the pools, were measured in each of the four groups (control, absence of exogenous pyruvate, but essentially prevented COHC, pyruvate, and pyruvate1COHC) of protocol II. In energetic enhancements by pyruvate. Thus, pyruvate did the absence of exogenous pyruvate, COHC increased not increase phosphocreatine content, phosphocreatine alanine content 4.6-fold (Fig. 3) ; thus, blockade of mitopotential, and cytosolic ATP phosphorylation potential in chondrial pyruvate uptake appeared to divert endogenous COHC-treated myocardium, relative to NaCl. pyruvate to the cytosolic transamination pathway. Citrate content was unaltered by COHC in these hearts; thus, 3.4. Cytosolic redox metabolites mitochondrial metabolism of endogenous pyruvate was not essential to establish the baseline level of citrate in hearts Intracellular pyruvate / lactate ratio can be taken as an metabolizing octanoate as exogenous energy substrate.
1 index of cytosolic NAD / NADH as prescribed by the Pyruvate increased myocardial alanine content 18-fold lactate dehydrogenase equilibrium [29] . Accordingly, inin the absence of COHC. The increase in alanine content Ci mol Ca for 6000 heart beats to effect radiolabeling 21 45 of intracellular Ca . Ca was then washed out by perfusion with 0.2 mM octanoate alone (control) or with additional 2.5 mM pyruvate in the absence or presence of 0.6 mM COHC. At 35 min washout, pyruvate elevated stroke work 40%, and COHC prevented pyruvate enhancement of stroke work (Fig. 4A) , as would be expected from the results of protocols I and II. Importantly, levels of II (see Fig. 2A decrease of 11.6 mmol g dry mass in the combined lowered Ca concentration in protocol III. contents of glutamate plus aspartate, the sources of amino Caffeine was infused from 40-50 min washout to 21 45 groups for alanine formation via glutamate-pyruvate and mobilize sarcoplasmic reticular Ca . Baseline Ca reglutamate-oxaloacetate transaminases. In pyruvate-perlease during the 3 min prior to caffeine infusion was fused myocardium, COHC did not lower and even tended essentially stable and did not differ among the three groups 21 21 to increase alanine content. COHC also augmented the (nCi min g dry mass ): control 7.560.7; pyruvate pyruvate-induced declines in glutamate and aspartate con-9.061.2; pyruvate1COHC 7.661.2. In control hearts, 45 21 tents (P,0.05; Fig. 3 ). In the absence of COHC, pyruvate caffeine released 0.28060.038 mCi Ca g dry mass increased myocardial citrate content 50-fold, from (Fig. 4B) induced Ca release by inhibiting caffeine-dependent lease were nearly identical among the three groups, and 21 14 mobilization of sarcoplasmic reticular Ca , rather than by C release fell to near the detection limit by 10 min 21 45 increasing sarcoplasmic reticular Ca turnover and Ca washout in each group. Analyses of washout curves from release prior to caffeine. If this were the case, the amount individual experiments revealed three kinetic components 45 of Ca remaining in the myocardium following caffeine (Table 2) . Importantly, the t and V values of these To address this possibility, residual Ca was measured in from the extracellular space. The anatomical origins of myocardium following 10 min caffeine infusion (Fig. 4C) .
these kinetic components cannot be determined with 45 certainty. However, comparison of these t and V Pyruvate did not increase residual myocardial Ca con-
values with those of kinetic components delineated in the tent; indeed, post-caffeine Ca content was nearly identiisolated heart study of Becker et al. [22] suggests that cal among the three groups. Thus, pyruvate did not lessen 45 45 component I may originate from the vasculature, comcaffeine-induced Ca release by sequestering Ca in the ponent II from the interstitium, and the smaller, slowly sarcoplasmic reticulum. These results further substantiate released component III from intracellular compartments, the concept that pyruvate increased sarcoplasmic reticular 21 indicating sucrose may have entered the cells to a limited Ca turnover, and that inhibition of mitochondrial pyru- 21 extent. vate metabolism attenuated pyruvate enhancement of Ca 14 Residual myocardial C content at 20 min washout was turnover.
nearly identical in the three groups (Fig. 5 inset) . When adjusted for the differences in left atrial inflow radioac- 14 14 45 3.7. C-Sucrose washout kinetics tivities during the labeling periods of the C vs. Ca 14 21 experiments, the approximately 3500 dpm C g dry at Two additional alternative explanations for the observed 20 min washout would be equivalent to no more than 0.1 45 45 21
effects of pyruvate and COHC on caffeine induced Ca mCi Ca g dry , even in the unlikely event that no 14 release could be proposed, if it is assumed that regions of additional C-sucrose release would have occurred at inadequate coronary flow developed during washout that 20-40 min washout. These data indicate that the bulk of 45 45 trapped Ca in cardiac extracellular spaces, and that the caffeine-released Ca did not originate from the reflow of these regions during caffeine infusion liberated extracellular compartment, and that the effects of pyruvate 45 45 the trapped Ca. In the first hypothetical scenario, pyruand COHC on caffeine induced Ca release could not be 45 45 vate and / or COHC altered the kinetics of Ca washout ascribed to differences in residual extracellular Ca from the extracellular space, such that different amounts of content prior to caffeine infusion as proposed in scenario 1.
45
Ca were trapped in the poorly perfused regions. In the The small amount of extracellular Ca also cannot ac-45 45 second scenario, the Ca washout kinetics were unaltered count for the differences in Ca release in even the most by pyruvate and / or COHC, but caffeine induced reflow of extreme case of scenario 2, wherein caffeine produces smaller portions of the pyruvate hearts than the other two complete reflow of control and COHC treated hearts, but groups. To test these alternatives, a modified protocol III no reflow of pyruvate treated hearts. Moreover, the near 45 was employed in which Ca was deleted from the labeling equivalence of stroke work in the protocol III hearts (Fig.   14 medium; instead, [U-C]sucrose was continuously infused 4A) with that of the analogous protocol II hearts ( Fig. 2A) , Table 2 14
Kinetic components of coronary venous washout of C-sucrose These findings confirm and extend recent reports in isolated working rabbit heart [11, 12] that cytosolic redox state and phosphorylation potential were poorly correlated.
We [3, 6] and others [4] have found pyruvate to be more 14 14 effective than other fuels including octanoate, lactate, reductants [11, 12, 30] . These other fuels differ from pyru- cytosolic energetics and sarcoplasmic reticular Ca transduring excitation-contraction coupling, tension developport as a mechanism for pyruvate enhancement of cardiac ment and muscle shortening, and is not expressed as inotropism [3] . However, it is recognized that these results external work [17, 18] . Thus, cardiac mechanical efficiency do not eliminate alternative scenarios wherein cytosolic is influenced by hemodynamic loading conditions and 21 pyruvate directly activates the sarcoplasmic reticular Ca heart rate, the principal determinants of heat production 21 ATPase and / or sarcolemmal Ca channel, and COHC associated with cardiac mechanical activity [17] . In this directly antagonizes these effects. Such hypothetical direct study, preload, afterload and heart rate were essentially 21 actions of pyruvate and COHC on Ca transport mechaidentical in the different groups, so it is unlikely that nisms could produce the inotropic effects observed in this pyruvate increased efficiency by decreasing contractile study. Although such direct effects of pyruvate and COHC heat. Cardiac efficiency can also be modulated to a limited 21 on Ca ATPases and channels have not been demonextent by changes in substrate selection due to modest strated in myocardium, further research is necessary to differences in the ratio of ATP synthesized to oxygen delineate the specific mediators of the linkage between reduced, i.e. the P/ O ratio. The P/ O ratio of pyruvate is mitochondrial pyruvate oxidation and sarcoplasmic reticu-3.0, 8% above the octanoate P/ O ratio of 2.77. It is lar function in order to exclude these alternative mechadoubtful, however, that the slightly higher P/ O ratio is the nisms.
principal factor responsible for the increased mechanical efficiency of hearts metabolizing pyruvate. The P/ O ratio 4.2. Pyruvate enhancement of cardiac mechanical for glucose is 3.17, even greater than that of pyruvate, yet efficiency mechanical efficiencies of glucose perfused hearts in our laboratory are approximately 10%, i.e. no greater than that Under aerobic conditions, cardiac mechanical efficiency of control hearts oxidizing octanoate, and well below that is defined as the portion of the enthalpy of consumed of hearts metabolizing pyruvate. 21 oxygen expressed as external work [17, 18] , equal to the Enhancement of sarcoplasmic reticular Ca transport ratio of stroke work to the energy equivalent of consumed secondary to increased cytosolic phosphorylation potential 21 O , estimated at 448 J mmol O [19] . Mechanical [3] could support increased mechanical efficiency by 2 2 21 efficiency was approximately 11% in control hearts oxienabling the sarcoplasmic reticular Ca pump to maintain 21 dizing octanoate as exogenous fuel, a level comparable to higher transmembrane Ca gradients resulting in augpreviously reported efficiencies of isolated, crystalloidmented diastolic relaxation and systolic contractile force. perfused working heart preparations [17, 31] . Pyruvate Arguably, a higher rate of oxidative phosphorylation and, increased stroke work 40% without increasing MVO , and, thus, MVO would be required to maintain a higher 2 2 thus, increased mechanical efficiency to nearly 15%. In cytosolic energetic state, if mitochondrial catabolism of these efficiency calculations, glycolytic ATP production, pyruvate were solely responsible for pyruvate's energetic which is independent of MVO , is assumed to be neglieffects. On the other hand, if cytosolic oxidation by 2 gible. Indeed, glycolytic flux was likely to be low in these pyruvate can elevate cytosolic energetics above the level hearts: exogenous glucose was not provided, and fatty acid sustained by oxidative phosphorylation, as occurs when oxidation inhibits glycolysis [32] . Pyruvate oxidation does mitochondrial pyruvate metabolism is unimpeded, sarcop-21 not increase and likely further inhibits glycolysis by lasmic reticular Ca uptake could be augmented without elevating citrate, an inhibitor of phosphofructokinase [33] an increase in O demand. According to this scenario, both 2 and by lowering cytosolic concentrations of the phosphomitochondrial catabolism and cytosolic oxidation could fructokinase activators ADP, AMP and P secondary to contribute to the favorable effects of pyruvate on cardiac i enhancement of cytosolic energetics. function and efficiency. [36] . Several investigations in mamDue to extensive binding and compartmentation of ADP,
